Literature DB >> 22050655

Sorafenib monotherapy gives sustainable suppression of FLT3 clone in untreated patients with FLT3-internal tandem duplication positive acute myeloid Leukaemia.

Babu P Mohan, Gee-fung How, Yvonne Loh, Yeh-ching Linn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22050655     DOI： 10.1111/j.1365-2141.2011.08910.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FMS-like tyrosine kinase 3 internal tandem duplications-positive acute myeloid leukemia cells.

Authors:  Guiyun Song; Benigno C Valdez; Yang Li; Yan Liu; Richard E Champlin; Borje S Andersson
Journal:  Biol Blood Marrow Transplant       Date:  2014-08-09       Impact factor: 5.742

Review 2.  Precision therapy for acute myeloid leukemia.

Authors:  Xue Yang; Jianxiang Wang
Journal:  J Hematol Oncol       Date:  2018-01-05       Impact factor: 17.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.